Peroxisome Proliferator Activated Receptor Ligands as Regulators of Airway Inflammation and Remodelling in Chronic Lung Disease
Inflammation is a major component in the pathology of chronic lung diseases, including asthma. Anti-inflammatory treatment with corticosteroids is not effective in all patients. Thus, new therapeutic options are required to control diverse cellular functions that are currently not optimally targ...
Saved in:
| Main Authors: | Jane Elizabeth Ward, Xiahui Tan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2007-01-01
|
| Series: | PPAR Research |
| Online Access: | http://dx.doi.org/10.1155/2007/14983 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Activation and Molecular Targets of Peroxisome Proliferator-Activated Receptor-γ Ligands in Lung Cancer
by: Raphael A. Nemenoff, et al.
Published: (2008-01-01) -
Role of Peroxisome Proliferator-Activated Receptor-γ in Vascular Inflammation
by: Kousei Ohshima, et al.
Published: (2012-01-01) -
Examination of Ligand-Dependent Coactivator Recruitment by Peroxisome Proliferator-Activated Receptor-α (PPARα)
by: Eric S. Tien, et al.
Published: (2006-01-01) -
Peroxisome Proliferator Activator Receptor (PPAR)-γ Ligand, but Not PPAR-α, Ameliorates Cyclophosphamide-Induced Oxidative Stress and Inflammation in Rat Liver
by: Azza A. K. El-Sheikh, et al.
Published: (2014-01-01) -
Chondrosarcoma and Peroxisome Proliferator-Activated Receptor
by: K. Hashizume, et al.
Published: (2008-01-01)